This NIH R21 Exploratory/Developmental grant is for supporting innovative investigations in primary immunodeficiency diseases. Its purpose is to advance research through ex vivo studies using human specimens and investigations with new or existing animal models. The grant encourages the development of novel clinical strategies for detecting, identifying the molecular basis of, or creating innovative therapies for these diseases. It specifically welcomes applications from investigators who have not previously received independent NIH funding or who are new to this specific research field. Approximately $650,000 is anticipated to fund two new awards each fiscal year, contingent on fund availability and the submission of meritorious applications. The mechanism utilized is the NIH Exploratory/Developmental (R21) award.
Opportunity ID: 53019
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAS-10-148 |
| Funding Opportunity Title: | Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy, Immunology and Transplantation Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 22, 2010 |
| Last Updated Date: | Feb 21, 2013 |
| Original Closing Date for Applications: | May 07, 2013 |
| Current Closing Date for Applications: | Sep 07, 2013 |
| Archive Date: | Oct 07, 2013 |
| Estimated Total Program Funding: | $650,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) County governments Public and State controlled institutions of higher education Private institutions of higher education State governments Special district governments Small businesses City or township governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to support innovative exploratory/developmental investigations in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for, primary immunodeficiency diseases. Investigators who have no prior history of receiving independent NIH funding or no prior history of receiving independent NIH funding in this field are encouraged to apply to this FOA. Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-147, that encourages applications under the R03 small grant mechanism. Funds Available and Anticipated Number of Awards. It is anticipated that approximately $650,000 will be available under this FOA and that 2 new awards will be made each fiscal year. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAS-10-148.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Version History
| Version | Modification Description | Updated Date |
|---|---|---|
| Modified Archive Date based on new Expiration Date, per NOT-AI-13-028. | Feb 21, 2013 | |
| Feb 21, 2013 |
DISPLAYING: Synopsis 2
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAS-10-148 |
| Funding Opportunity Title: | Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy, Immunology and Transplantation Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 2 |
| Posted Date: | Mar 22, 2010 |
| Last Updated Date: | Feb 21, 2013 |
| Original Closing Date for Applications: | May 07, 2013 |
| Current Closing Date for Applications: | Sep 07, 2013 |
| Archive Date: | Oct 07, 2013 |
| Estimated Total Program Funding: | $650,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Public housing authorities/Indian housing authorities Others (see text field entitled “Additional Information on Eligibility” for clarification) Independent school districts Native American tribal organizations (other than Federally recognized tribal governments) County governments Public and State controlled institutions of higher education Private institutions of higher education State governments Special district governments Small businesses City or township governments Native American tribal governments (Federally recognized) Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education For profit organizations other than small businesses |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to support innovative exploratory/developmental investigations in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for, primary immunodeficiency diseases. Investigators who have no prior history of receiving independent NIH funding or no prior history of receiving independent NIH funding in this field are encouraged to apply to this FOA. Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-147, that encourages applications under the R03 small grant mechanism. Funds Available and Anticipated Number of Awards. It is anticipated that approximately $650,000 will be available under this FOA and that 2 new awards will be made each fiscal year. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAS-10-148.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
DISPLAYING: Synopsis 1
General Information
| Document Type: | Grants Notice |
| Funding Opportunity Number: | PAS-10-148 |
| Funding Opportunity Title: | Exploratory/Developmental Investigations on Primary Immunodeficiency Diseases (R21) |
| Opportunity Category: | Discretionary |
| Opportunity Category Explanation: | – |
| Funding Instrument Type: | Grant |
| Category of Funding Activity: | Health Income Security and Social Services |
| Category Explanation: | – |
| Expected Number of Awards: | – |
| Assistance Listings: | 93.855 — Allergy, Immunology and Transplantation Research |
| Cost Sharing or Matching Requirement: | No |
| Version: | Synopsis 1 |
| Posted Date: | Feb 21, 2013 |
| Last Updated Date: | – |
| Original Closing Date for Applications: | – |
| Current Closing Date for Applications: | May 07, 2013 |
| Archive Date: | Jun 07, 2013 |
| Estimated Total Program Funding: | $650,000 |
| Award Ceiling: | $200,000 |
| Award Floor: | – |
Eligibility
| Eligible Applicants: | Public and State controlled institutions of higher education Public housing authorities/Indian housing authorities Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education Independent school districts City or township governments Private institutions of higher education Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education Small businesses State governments County governments Native American tribal organizations (other than Federally recognized tribal governments) Others (see text field entitled “Additional Information on Eligibility” for clarification) Native American tribal governments (Federally recognized) For profit organizations other than small businesses Special district governments |
| Additional Information on Eligibility: | Other Eligible Applicants include the following: Alaska Native and Native Hawaiian Serving Institutions; Eligible Agencies of the Federal Government; Faith-based or Community-based Organizations; Hispanic-serving Institutions; Historically Black Colleges and Universities (HBCUs); Indian/Native American Tribal Governments (Other than Federally Recognized); Regional Organizations; Tribally Controlled Colleges and Universities (TCCUs) ; U.S. Territory or Possession. |
Additional Information
| Agency Name: | National Institutes of Health |
| Description: | Purpose. The purpose of this Funding Opportunity Announcement (FOA) is to support innovative exploratory/developmental investigations in primary immunodeficiency diseases focusing on ex vivo studies with human specimens and on studies with current or new animal models, including novel clinical strategies for detecting, identifying the molecular basis of, or developing innovative therapies for, primary immunodeficiency diseases. Investigators who have no prior history of receiving independent NIH funding or no prior history of receiving independent NIH funding in this field are encouraged to apply to this FOA. Mechanism of Support. This FOA will use the NIH Exploratory/Developmental (R21) award mechanism and runs in parallel with a FOA of identical scientific scope, PA-10-147, that encourages applications under the R03 small grant mechanism. Funds Available and Anticipated Number of Awards. It is anticipated that approximately $650,000 will be available under this FOA and that 2 new awards will be made each fiscal year. Awards issued under this FOA are contingent upon the availability of funds and the submission of a sufficient number of meritorious applications. |
| Link to Additional Information: | http://grants.nih.gov/grants/guide/pa-files/PAS-10-148.html |
| Grantor Contact Information: | If you have difficulty accessing the full announcement electronically, please contact:
NIH OER Webmaster
FBOWebmaster@OD.NIH.GOV Email:FBOWebmaster@OD.NIH.GOV |
Related Documents
There are no related documents on this grant.
Packages
| Agency Contact Information: | NIH OER Webmaster FBOWebmaster@OD.NIH.GOV Email: FBOWebmaster@OD.NIH.GOV |
| Who Can Apply: | Organization Applicants |
| Assistance Listing Number | Competition ID | Competition Title | Opportunity Package ID | Opening Date | Closing Date | Actions |
|---|---|---|---|---|---|---|
| ADOBE-FORMS-B1 | Supersedes ADOBE-FORMS-B | PKG00022367 | Nov 04, 2010 | Sep 07, 2013 | View | |
| ADOBE-FORMS-B | Use for submissions intended for due dates of January 25, 2010 and beyond | PKG00017371 | May 16, 2010 | Nov 04, 2010 | View |
Package 1
Mandatory forms
53019 RR_SF424_1_2-1.2.pdf
53019 RR_OtherProjectInfo_1_3-1.3.pdf
53019 RR_KeyPersonExpanded_1_2-1.2.pdf
53019 PerformanceSite_1_4-1.4.pdf
53019 PHS398_ResearchPlan_1_3-1.3.pdf
53019 PHS398_CoverPageSupplement_1_4-1.4.pdf
53019 PHS398_Checklist_1_3-1.3.pdf
Optional forms
53019 RR_Budget-1.1.pdf
53019 RR_SubawardBudget-1.2.pdf
53019 PHS_CoverLetter_1_2-1.2.pdf
53019 PHS398_ModularBudget-1.1.pdf
Package 2
Mandatory forms
53019 RR_SF424_1_2-1.2.pdf
53019 PerformanceSite_1_3-1.3.pdf
53019 RR_OtherProjectInfo_1_2-1.2.pdf
53019 RR_KeyPersonExpanded_1_2-1.2.pdf
53019 PHS398_CoverPageSupplement_1_4-1.4.pdf
53019 PHS398_ResearchPlan_1_3-1.3.pdf
53019 PHS398_Checklist_1_3-1.3.pdf
Optional forms
53019 PHS_CoverLetter_1_2-1.2.pdf
53019 PHS398_ModularBudget-1.1.pdf
53019 RR_Budget-1.1.pdf
53019 RR_SubawardBudget-1.2.pdf
Share This Post, Choose Your Platform!
About the Author: osnqt
